Carlos G Vanoye1, Reshma R Desai1, Katarina L Fabre1, Shannon L Gallagher1, Franck Potet1, Jean-Marc DeKeyser1, Daniela Macaya2, Jens Meiler3,4, Charles R Sanders5,4, Alfred L George1. 1. Department of Pharmacology, Northwestern University Feinberg School of Medicine, Chicago, IL (C.G.V., R.R.D., K.L.F., S.L.G., F.P., J.-M.D., A.L.G.). 2. GeneDx, Inc, Gaithersburg, MD (D.M.). 3. Department of Chemistry, Vanderbilt University School of Medicine, Nashville, TN (J.M.). 4. the Center for Structural Biology, Vanderbilt University School of Medicine, Nashville, TN (J.M.,C.R.S.). 5. Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, TN (C.R.S.).
Abstract
BACKGROUND: The explosive growth in known human gene variation presents enormous challenges to current approaches for variant classification that have implications for diagnosis and treatment of many genetic diseases. For disorders caused by mutations in cardiac ion channels as in congenital arrhythmia syndromes, in vitro electrophysiological evidence has high value in discriminating pathogenic from benign variants, but these data are often lacking because assays are cost, time, and labor intensive. METHODS: We implemented a strategy for performing high-throughput functional evaluations of ion channel variants that repurposed an automated electrophysiological recording platform developed previously for drug discovery. RESULTS: We demonstrated the success of this approach by evaluating 78 variants in KCNQ1, a major gene involved in genetic disorders of cardiac arrhythmia susceptibility. We benchmarked our results with traditional electrophysiological approaches and observed a high level of concordance. This strategy also enabled studies of dominant-negative behavior of variants exhibiting severe loss-of-function. Overall, our results provided functional data useful for reclassifying >65% of the studied KCNQ1 variants. CONCLUSIONS: Our results illustrate an efficient and high-throughput paradigm linking genotype to function for a human cardiac ion channel that will enable data-driven classification of large numbers of variants and create new opportunities for precision medicine.
BACKGROUND: The explosive growth in known human gene variation presents enormous challenges to current approaches for variant classification that have implications for diagnosis and treatment of many genetic diseases. For disorders caused by mutations in cardiac ion channels as in congenital arrhythmia syndromes, in vitro electrophysiological evidence has high value in discriminating pathogenic from benign variants, but these data are often lacking because assays are cost, time, and labor intensive. METHODS: We implemented a strategy for performing high-throughput functional evaluations of ion channel variants that repurposed an automated electrophysiological recording platform developed previously for drug discovery. RESULTS: We demonstrated the success of this approach by evaluating 78 variants in KCNQ1, a major gene involved in genetic disorders of cardiac arrhythmia susceptibility. We benchmarked our results with traditional electrophysiological approaches and observed a high level of concordance. This strategy also enabled studies of dominant-negative behavior of variants exhibiting severe loss-of-function. Overall, our results provided functional data useful for reclassifying >65% of the studied KCNQ1 variants. CONCLUSIONS: Our results illustrate an efficient and high-throughput paradigm linking genotype to function for a human cardiac ion channel that will enable data-driven classification of large numbers of variants and create new opportunities for precision medicine.
Entities:
Keywords:
electrophysiology; ion channels; long QT syndrome; mutation; potassium channels
Authors: U Gerlach; J Brendel; H J Lang; E F Paulus; K Weidmann; A Brüggemann; A E Busch; H Suessbrich; M Bleich; R Greger Journal: J Med Chem Date: 2001-11-08 Impact factor: 7.446
Authors: Kara N Maxwell; Steven N Hart; Joseph Vijai; Kasmintan A Schrader; Thomas P Slavin; Tinu Thomas; Bradley Wubbenhorst; Vignesh Ravichandran; Raymond M Moore; Chunling Hu; Lucia Guidugli; Brandon Wenz; Susan M Domchek; Mark E Robson; Csilla Szabo; Susan L Neuhausen; Jeffrey N Weitzel; Kenneth Offit; Fergus J Couch; Katherine L Nathanson Journal: Am J Hum Genet Date: 2016-05-05 Impact factor: 11.025
Authors: Paul A Brink; Lia Crotti; Valerie Corfield; Althea Goosen; Glenda Durrheim; Paula Hedley; Marshall Heradien; Gerhard Geldenhuys; Emilio Vanoli; Sara Bacchini; Carla Spazzolini; Andrew L Lundquist; Dan M Roden; Alfred L George; Peter J Schwartz Journal: Circulation Date: 2005-10-25 Impact factor: 29.690
Authors: Kui Hong; David R Piper; Aurora Diaz-Valdecantos; Josep Brugada; Antonio Oliva; Elena Burashnikov; José Santos-de-Soto; Josefina Grueso-Montero; Ernesto Diaz-Enfante; Pedro Brugada; Frank Sachse; Michael C Sanguinetti; Ramon Brugada Journal: Cardiovasc Res Date: 2005-08-18 Impact factor: 10.787
Authors: Troy E Rhodes; Robert L Abraham; Richard C Welch; Carlos G Vanoye; Lia Crotti; Marianne Arnestad; Roberto Insolia; Matteo Pedrazzini; Chiara Ferrandi; Ashild Vege; Torleiv Rognum; Dan M Roden; Peter J Schwartz; Alfred L George Journal: J Mol Cell Cardiol Date: 2007-12-07 Impact factor: 5.000
Authors: Bian Li; Jeffrey L Mendenhall; Brett M Kroncke; Keenan C Taylor; Hui Huang; Derek K Smith; Carlos G Vanoye; Jeffrey D Blume; Alfred L George; Charles R Sanders; Jens Meiler Journal: Circ Cardiovasc Genet Date: 2017-10
Authors: Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm Journal: Genet Med Date: 2015-03-05 Impact factor: 8.822
Authors: Krystian A Kozek; Andrew M Glazer; Chai-Ann Ng; Daniel Blackwell; Christian L Egly; Loren R Vanags; Marcia Blair; Devyn Mitchell; Kenneth A Matreyek; Douglas M Fowler; Bjorn C Knollmann; Jamie I Vandenberg; Dan M Roden; Brett M Kroncke Journal: Heart Rhythm Date: 2020-06-06 Impact factor: 6.343
Authors: Anand N Ganesan; Carlos G Vanoye; Ferdous Alam; Kathryn E Waddell-Smith; Andrew D McGavigan; Gemma Correnti; Eric Haan; Alex Brown; Jamie Vandenberg; Alfred L George Journal: Circ Genom Precis Med Date: 2020-01-31
Authors: Andrew M Glazer; Yuko Wada; Bian Li; Ayesha Muhammad; Olivia R Kalash; Matthew J O'Neill; Tiffany Shields; Lynn Hall; Laura Short; Marcia A Blair; Brett M Kroncke; John A Capra; Dan M Roden Journal: Am J Hum Genet Date: 2020-06-12 Impact factor: 11.025
Authors: Seok Kyu Kang; Carlos G Vanoye; Sunita N Misra; Dennis M Echevarria; Jeffrey D Calhoun; John B O'Connor; Katarina L Fabre; Dianalee McKnight; Laurie Demmer; Paula Goldenberg; Lauren E Grote; Isabelle Thiffault; Carol Saunders; Kevin A Strauss; Ali Torkamani; Jasper van der Smagt; Koen van Gassen; Robert P Carson; Jullianne Diaz; Eyby Leon; Joseph E Jacher; Mark C Hannibal; Jessica Litwin; Neil R Friedman; Allison Schreiber; Bryan Lynch; Annapurna Poduri; Eric D Marsh; Ethan M Goldberg; John J Millichap; Alfred L George; Jennifer A Kearney Journal: Ann Neurol Date: 2019-10-24 Impact factor: 10.422
Authors: Weixing Shen; Wenjie Ren; Shenyu Zhai; Ben Yang; Carlos G Vanoye; Ananya Mitra; Alfred L George; D James Surmeier Journal: J Clin Invest Date: 2020-05-01 Impact factor: 14.808
Authors: Georg Kuenze; Carlos G Vanoye; Reshma R Desai; Sneha Adusumilli; Kathryn R Brewer; Hope Woods; Eli F McDonald; Charles R Sanders; Alfred L George; Jens Meiler Journal: Elife Date: 2020-10-23 Impact factor: 8.140